drugset / Trial / NCT07410806
HEALEY ALS Platform Trial - Regimen I NUZ-001
Phase 2/3
Active not recruiting
240 enrolled
Merit E. Cudkowicz, MD
Neurizon Therapeutics Limited · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen I will evaluate the safety and efficacy of a single study drug, NUZ-001, in participants with ALS.
Timeline
- Start
- 2026-02-25
- Primary completion
- 2027-07-01
- Completion
- 2028-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NUZ-001 | Unknown | — | Oral |